173 related articles for article (PubMed ID: 37648277)
1. Poorly differentiated orbital neuroendocrine carcinoma.
Zhang YS; Jiro M; Pekmezci M; Winn B
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37648277
[TBL] [Abstract][Full Text] [Related]
2. Small cell neuroendocrine carcinoma with primary orbital involvement - The unseen, and a review of literature.
Agrawal S; Deora A; Sen S; Gupta S; Das D
Indian J Pathol Microbiol; 2023; 66(1):155-158. PubMed ID: 36656229
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine tumour metastasis to the orbit.
Kozubowska K; Skorek A; Pęksa R
Endokrynol Pol; 2019; 70(5):455-456. PubMed ID: 31135056
[TBL] [Abstract][Full Text] [Related]
4. The eye of the beholder: orbital metastases from midgut neuroendocrine tumors, a two institution experience.
Das S; Pineda G; Goff L; Sobel R; Berlin J; Fisher G
Cancer Imaging; 2018 Dec; 18(1):47. PubMed ID: 30522522
[TBL] [Abstract][Full Text] [Related]
5. Orbital metastasis from neuroendocrine tumour: Case report and literature review.
Albanese G; Harieaswar S; Sampath R
Eur J Ophthalmol; 2022 Sep; 32(5):2498-2504. PubMed ID: 34787007
[TBL] [Abstract][Full Text] [Related]
6. Small cell neuroendocrine carcinoma masquerading as cellulitis and causing blindness via bilateral orbital involvement.
Atik A; Krilis M; Shannon K
Orbit; 2013 Jun; 32(3):197-9. PubMed ID: 23514048
[TBL] [Abstract][Full Text] [Related]
7. Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas--a single institution experience.
Görner M; Brasch F; Hirnle P; Gehl HB; Scholtz LU; Wegehenkel K; Sudhoff H
Eur J Cancer Care (Engl); 2013 Sep; 22(5):648-52. PubMed ID: 23701280
[TBL] [Abstract][Full Text] [Related]
8. Previously undiagnosed neuroendocrine tumour mimicking breast cancer metastasis to the orbit.
Bacorn C; Kim E; Borowsky AD; Lin LK
BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32439746
[TBL] [Abstract][Full Text] [Related]
9. Clinico-radiological findings of neuroendocrine tumour metastases to the orbit.
Ryan TG; Juniat V; Stewart C; Malhotra R; Hardy TG; McNab AA; Davis G; Selva D
Orbit; 2022 Feb; 41(1):44-52. PubMed ID: 33729098
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic primary rectal neuroendocrine carcinoma presented as a large pelvic mass.
Pittayanon R; Pantongrag-Brown L; Wisedopas N; Rerknimitr R
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24493107
[TBL] [Abstract][Full Text] [Related]
11. Bilateral orbital metastases from a neuroendocrine tumor.
Sivagnanavel V; Riordan-Eva P; Jarosz J; Portmann B; Buxton-Thomas M
J Neuroophthalmol; 2004 Sep; 24(3):240-2. PubMed ID: 15348994
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study.
Hainsworth JD; Spigel DR; Litchy S; Greco FA
J Clin Oncol; 2006 Aug; 24(22):3548-54. PubMed ID: 16877720
[TBL] [Abstract][Full Text] [Related]
13. Bilateral Neuroendocrine Carcinoma of Breast: A Case Report.
Neupane S; Dhakal S; Walawalakar S; Parajuli SB; Sapkota S
JNMA J Nepal Med Assoc; 2021 Dec; 59(244):1320-1322. PubMed ID: 35199786
[TBL] [Abstract][Full Text] [Related]
14. Metastatic neuroendocrine tumor masquerading as orbital cysticercosis.
Wirth MA; Khan HM; Sabiq F; Agoumi M; Neufeld A
Neuroradiol J; 2023 Apr; 36(2):229-231. PubMed ID: 36044662
[TBL] [Abstract][Full Text] [Related]
15. Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.
Bruera G; Giuliani A; Romano L; Chiominto A; Di Sibio A; Mastropietro S; Cosenza P; Ricevuto E; Schietroma M; Carlei F;
BMC Cancer; 2019 Oct; 19(1):960. PubMed ID: 31619203
[TBL] [Abstract][Full Text] [Related]
16. Orbital lymphoma simulating thyroid orbitopathy.
Payne JF; Shields CL; Eagle RC; Shields JA
Ophthalmic Plast Reconstr Surg; 2006; 22(4):302-4. PubMed ID: 16855508
[TBL] [Abstract][Full Text] [Related]
17. Metastatic Orbital Tumor From Breast Ductal Carcinoma With Neuroendocrine Differentiation Initially Presenting as Ocular Symptoms: A Case Report and Literature Review.
Togashi K; Nishitsuka K; Hayashi S; Namba H; Goto S; Takeda Y; Suzuki S; Kato T; Yamada Y; Konno E; Yoshioka T; Yamakawa M; Sonoda Y; Suzuki T; Yamashita H
Front Endocrinol (Lausanne); 2021; 12():625663. PubMed ID: 33692758
[TBL] [Abstract][Full Text] [Related]
18. High-grade large cell neuroendocrine carcinoma of the esophagus: a case report and review of the literature.
Awada H; Hajj Ali A; Bakhshwin A; Daw H
J Med Case Rep; 2023 Apr; 17(1):144. PubMed ID: 37024958
[TBL] [Abstract][Full Text] [Related]
19. Study of aggressive carcinomas through orbital metastasis.
Espinosa-Barberi G; Alba Linero C; Galván González FJ; Álvarez González E; Rey López A; Medina Rivero F
Arch Soc Esp Oftalmol (Engl Ed); 2019 May; 94(5):252-256. PubMed ID: 30578070
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas.
Frizziero M; Spada F; Lamarca A; Kordatou Z; Barriuso J; Nuttall C; McNamara MG; Hubner RA; Mansoor W; Manoharan P; Fazio N; Valle JW
Neuroendocrinology; 2019; 109(2):100-112. PubMed ID: 30703770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
